Diltiazem CD — Class III drug recall D-0715-2018
Terminated recall by Mckesson Packaging Services, reported 2018-05-02, distributed nationwide. Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
| Recall number | D-0715-2018 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Mckesson Packaging Services, Concord, NC, United States |
| Recall initiated | 2018-04-23 |
| Classified | 2018-05-07 |
| Reported by FDA | 2018-05-02 |
| Terminated | 2020-10-13 |
| Distributed | Nationwide (US) |
| Quantity | 7,656 cartons |
| Reason classes | specification failure |
| NDC | 63739-0284-10 |
| Lot numbers | 0114214 |
| Expiration dates | 2018-09 |
Product
Diltiazem CD (Diltiazem Hydrochloride Extended-Release Capsules, USP) 180 mg, 100-count bottles, Rx Only Mfg. By: Actavis 60 Columbia Rd., Bldg. B Morristown, NJ 07960. NDC 63739-284-10
Reason for recall
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0715-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.